transport of lipids through the aqueous plasma milieu to ensure lipid delivery for a wide variety of metabolic functions. 1 Contrary to most lipoproteins, the physiological function of lipoprotein(a) [Lp(a)] and the consequence of an extreme concentration of Lp(a) remain incompletely understood. Increased cardiovascular disease (CVD) risk has been associated with elevated plasma Lp(a) concentration, [2] [3] [4] though somewhat inconsistently between populations. 5, 6 Although the precise pathogenic mechanisms underlying the association remain unknown, both atherogenic and prothrombotic pathways have been suggested, possibly involving inflammation, 7 endothelial dysfunction, 8 interaction with platelet function, 9 or plasminogen activation. 10 
Clinical Perspective on p 46
Lp(a) comprises a single large apolipoprotein(a) [apo(a)] connected through a disulfide bond to the apolipoprotein (apo) B moiety of a cholesterol-rich low-density lipoprotein (LDL) cholesterol particle. 11 Apo(a) is extremely heterogeneous in size, which is the result of a genetically determined functional copy number variation within the LPA gene (OMIM: 15220) on chromosome 6q27. 11 Each additional genomic copy of the tandem repeat region contains 2 exons that code for a protein domain called kringle IV type 2 (KIV-2). 11 The mature apo(a) particle has a KIV-2 copy number range of 5 to Ͼ50 domains across human populations, with larger protein isoforms being compromised with respect to protein folding, transport, and secretion. 11 Association between plasma Lp(a) concentration and KIV-2 repeat number has been identified. 12 Null alleles, in which the LPA gene contains either a truncation mutation or an extremely large number of KIV-2 repeats and, thus, does not produce a secreted protein, have been identified but are uncommon. 13 Beyond its effect on the concentration of plasma Lp(a), other functions of the KIV-2 repeat are unknown, but associations between low KIV-2 copy number and CVD have been consistently reported. 14 -16 Recently, a large Mendelian randomization study reported association between low KIV-2 copy number and myocardial infarction in a sample of European Caucasians but did not include single-nucleotide polymorphism (SNP) genotypes. 17 To date, KIV-2 copy number generally has been identified either at the biochemical level by examining the protein size using electrophoresis and immunoblotting 18, 19 or at the genomic level using pulse-field gel electrophoresis with Southern blotting of unamplified genomic DNA. 19 Because of the requirement of either large amounts of fresh plasma or genomic DNA, respectively, for these methods, candidategene and genome-wide association studies of Lp(a) concentration have not included the apo(a) KIV-2 copy number as a covariate or independent variable, nor has there been any opportunity to study association or linkage disequilibrium between LPA SNPs and KIV-2 copy number. To address these issues, we genotyped a multiethnic sample for both SNPs, using a targeted CVD SNP microarray, and KIV-2 copy number, using a quantitative polymerase chain reaction (PCR) method. 20
Methods

Subjects
The Study of Health Assessment and Risk in Ethnic Groups (SHARE) cohort was collected for a prospective population-based assessment of traditional and novel CVD risk factors in Canada. 21 As previously described, all participants resided in Hamilton or Toronto, Ontario, or Edmonton, Alberta, for at least 5 years and were classified as South Asian (nϭ330) if their ancestors originated from India, Pakistan, Sri Lanka, or Bangladesh; Chinese (nϭ304) if their ancestors originated from China, Taiwan, or Hong Kong; and European Caucasian (nϭ272) if their ancestors originated from Europe. 21, 22 Description of participant ascertainment, selection, and exclusion as well as biochemical and anthropometric measurement techniques have been previously described. 21 For Lp(a) specifically, quantitative measurements were made with automated immunoprecipitation and turbidimetric detection using the Incstar Lp(a) test kit on the Ciba-Corning 550 EXPRESS. 21 Baseline anthropometric measures are presented in Table 1 . The study was approved by the ethics review boards of both McMaster University and the University of Western Ontario. All participants provided informed consent for genetic analysis. The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agreed to the manuscript as written.
LPA SNP Genotyping
Genomic DNA was extracted from leukocytes as previously described. 23 SNP genotypes were produced with the Illumina Human CVD beadchip 24 scanned on the Illumina BeadStation 500G at the Centre for Applied Genomics (Hospital for Sick Children, Toronto, Ontario, Canada; www.tcag.ca). The Illumina CVD beadchip contains Ϸ50 000 SNPs, densely mapping Ϸ2000 genes with potential roles in cardiovascular, metabolic, and inflammatory phenotypes. 24 Genotyping and quality control were performed in the Illumina BeadStudio Genotyping Module version 3.2. Eight replicate chip assays were performed, with an average of 5.7 nonconforming calls per replicate, giving an overall accuracy of Ͼ99.99%. Sixteen individuals (1.8%) were excluded due to SNP call rates Ͻ95%, and 1151 (2.3%) SNPs were excluded due to genotype call rates Ͻ95%. SNPs that were not in Hardy-Weinberg equilibrium (PϽ0.0001) or with a minor allele frequency Ͻ0.01 were excluded, leaving 35 303, 31 751, and 35 018 SNPs genotyped in South Asian, Chinese, and European Caucasian samples, respectively.
LPA KIV-2 Copy Number Genotyping
The number of KIV-2 repeats was determined using a previously described quantitative PCR-based approach. 20 Briefly, a multiplexed quantitative PCR was performed containing alternatively labeled fluorescent probes for an exon in the KIV-2 domain and in a control region of the genome. The relative difference in fluorescence between probes, as measured by the difference in PCR cycle threshold (⌬C T ), can be used to estimate the kringle-repeat number. Taqman RNase P (RNAP) control reagent was used as the singlecopy reference gene (Part Number 4316844), and the quantitative PCR was performed in the Applied Biosystems 7900HT Fast Real-Time PCR system. To ensure accuracy of results, all reactions were performed in triplicate; primers and fluorescent-labeled probes were designed for exonic sequence containing no reported SNPs; and the experiment was performed for probes targeted to exons 4 and 5 of LPA, each of which is found once within every KIV-2 repeat at the genomic level. 20 Small modifications to the original protocol 20 included a reduction of total reaction volume to 10 L, a switch to Applied Biosystems Taqman Genotyping Master Mix (Part Number 4371357), and the use of a fixed cycle threshold of 0.2. As expected, a correlation was observed between the cycle threshold for the probe for exon 4 (⌬C T 4) and the cycle threshold for the probe for exon 5 (⌬C T 5) (South Asians, r s ϭ0.69, PϽ1ϫ10 Ϫ31 ; Chinese, r s ϭ0.79, PϽ1ϫ10 Ϫ31 ; European Caucasians, r s ϭ0.69, PϽ1ϫ10 Ϫ31 ). A discrepancy between ⌬C T 4 and ⌬C T 5, defined as a difference between ⌬C T 4 and ⌬C T 5 Ͼ2 SDs from the mean difference, was identified in 64 individuals (7%), all of which were resolved when retested. A collection of calibration samples could theoretically be used to approximate the number of KIV-2 protein domains; however, no distinct clusters of ⌬C T values were identified, and we considered that rounding to estimated KIV-2 protein domain number might result in loss of signal. Thus, the KIV-2 copy number determination cited henceforth refers to the mean of ⌬C T 4 and ⌬C T 5, as previously described. 20
Statistical Analysis
To obtain a normal distribution of plasma Lp(a) concentration, the square root of the plasma Lp(a) concentration was calculated. 17 KIV-2 copy number and square root-transformed Lp(a) concentration were compared among ethnicities using the Student t test.
Correlations between ⌬C T 4 and ⌬C T 5 and between KIV-2 copy number and Lp(a) concentration were performed using the nonparametric Spearman's rank correlation coefficient as implemented in SAS version 9.1. Linear regression was used to test the association between the number of minor alleles at a SNP and both plasma Lp(a) concentration and KIV-2 copy number, as implemented in PLINK, in each ethnicity independently. 25 Age and sex were included as covariates for all tests of association with plasma Lp(a) concentration. Population structure in the SHARE cohort was assessed using principal components in the program EIGENSTRAT, 26 and pairwise identity by state followed by multidimensional scaling as implemented in PLINK. 25 Three distinct homogeneous clusters were observed using either analytic technique. All the study participants clustered with their self-reported ethnicity with the exception of 2 individuals (0.2%) who were excluded from further analysis. 22 Within each of the ethnic subgroups of the SHARE cohort, further correction for population stratification was not required as the genomic control inflation factor was 1.00 when using all SNPs found on the CVD beadchip and plasma Lp(a) concentration as the trait, including age and sex as covariates. Meta-analysis of the effect size in the independent ethnicities was performed using the METAL software package. 
Results
Association Between Kringle-Repeat Number and Lp(a)
Differences of both KIV-2 copy number distribution and plasma Lp(a) concentration were observed among the 3 ethnicities ( Figure 1 ). Significant Figure 2 ).
Genetic Structure of LPA
In total, 49 SNPs were genotyped within 100 kb of either side of LPA. A consistent haplotype block structure across the 3 ethnicities was observed ( Figure 3 ). One large haplotype block contained the 5Ј end of the LPA locus, including the hypervariable KIV-2 copy number variation, and the first 35 kb immediately upstream of LPA. A second haplotype block contained the 3Ј end of LPA, including the peptidase domain and the kringle type V domain. The plasminogen gene (PLG), and potentially additional cis-acting elements Ͼ35 kb upstream of LPA, lay within a separate upstream haplotype block.
To estimate linkage disequilibrium between SNPs in LPA and KIV-2 copy number, association testing was performed with KIV-2 copy number as a continuous trait. SNP rs10455872, which was present only in European Caucasians, was significantly associated with KIV-2 copy number (Pϭ7.2ϫ10 Ϫ5 ; Table 3 ). SNP rs6415084 was prevalent in all 3 ethnicities and associated with KIV-2 copy number in the same direction (Pϭ2.6ϫ10 Ϫ4 ; Table 3 ). Two additional SNPs in the 5Ј haplotype block of LPA were marginally associated with KIV-2 copy number, in the same direction in all 3 ethnicities (0.0018ϽPϽ0.0076; Table 3 ).
Association Between SNPs and Lp(a)
Of the 14 SNPs within the 5Ј LPA haplotype block that were prevalent in all 3 ethnicities, 10 SNPs were associated with plasma Lp(a) concentration in the same direction in all 3 ethnicities (0.001ϽPϽ2.5ϫ10 Ϫ9 ; Table 3 ). The minor alleles of particular SNPs within the 5Ј block were associated with both increased and decreased plasma Lp(a) concentration. One SNP, rs10455872, only present in European Caucasians, was very strongly associated with plasma Lp(a) concentration (Pϭ4.2ϫ10 Ϫ23 ). Two SNPs within the 3Ј LPA haplotype block rs11751605, found only in European Caucasians, and rs6919346, found in European Caucasians and South Asians, were observed to be associated with plasma Lp(a) concentration (Pϭ6.0ϫ10 Ϫ6 and Pϭ7.6ϫ10 Ϫ6 , respectively). Excluding the 100-kb region surrounding LPA, no SNPs found within the 20-Mb (150 to 170 Mb) region on 6q previously reported to be associated with Lp(a) concentration 27 were associated with Lp(a) concentration (PϾ1ϫ10 Ϫ3 ). As well, none of the other tested SNPs on the CVD beadchip were associated with plasma Lp(a) concentration (PϾ1ϫ10 Ϫ5 ).
To assess how KIV-2 copy number might modulate the association between SNPs and plasma Lp(a) concentration, regression analysis was performed with KIV-2 included as a covariate ( Table 3 , right column). For all SNPs that were significantly associated with plasma Lp(a) concentration, the significance was reduced with KIV-2 copy number included as a covariate, but all remained significant, even after multiple-testing correction (1.8ϫ10 Ϫ5 ϽPϽ2.8ϫ10 Ϫ19 ).
Genomic Contribution to Plasma Lp(a) Variation
To measure the contribution of the genotyped LPA variants to plasma Lp(a) concentration variation, we performed a multivariate multiple regression with a forward stepwise modeling approach. Including sex, LDL cholesterol, and apoB, a substantially larger proportion of plasma Lp(a) concentration variation could be explained in European Caucasians (r 2 ϭ0.36; F 4 ϭ34.96) compared with Chinese (r 2 ϭ0.27; F 7 ϭ15.44) or South Asians (r 2 ϭ0.21; F 5 ϭ16.35; Figure 4 ; supplemental Table I ). Likely contributing to this discrepancy was the strong association observed between rs10455872 and plasma Lp(a) concentration prevalent only in European Caucasians. For each group, the KIV-2 copy number explained an additional proportion of the variation in plasma Lp(a) compared with the SNP genotype alone.
Discussion
In a multiethnic sample of Ϸ900 individuals, we examined the genomic structure of the LPA locus and quantified its contribution to Lp(a) concentrations. The haplotype block structure was similar across the 3 studied ethnicities, and we identified SNPs within a large block over the 5Ј end of LPA that were significantly associated with both Lp(a) concentration and number of KIV-2 repeats. One SNP, rs10455872, only observed in European Caucasians, was very strongly associated with both KIV-2 copy number and plasma Lp(a) concentration. Two SNPs within the haplotype block covering the 3Ј end of LPA also were associated with plasma Lp(a) concentration.
Two previous studies have shown no correlation, or linkage disequilibrium, between LPA SNPs and KIV-2 copy number. 27, 28 One study used Southern blotting, 28 whereas the other used immunoblotting, 27 and thus, the sample sizes were very small (nϭ47 and nϭ63, respectively) and subject to the technical limitations of the methods discussed earlier. Without measurement of KIV-2 copy number, a recent study identified linkage disequilibrium between the (TTTTA) n promoter polymorphism and sequence variation 3Ј to the KIV-2 repeat in kringle IV types 8 and 10, all of which lie within the 5Ј LPA haplotype block. 29 Using a quantitative PCR KIV-2 genotyping technique, we estimated KIV-2 copy number across our complete sample and identified strong association between KIV-2 copy number and rs10455872 in European Caucasians. An additional SNP, rs6415084, located in the 5Ј haplotype block and associated with both KIV-2 copy number and Lp(a) concentration is prevalent in all 3 ethnicities. Two additional SNPs, rs13202636 and rs3798221, were associated with Lp(a) concentration and were margin-ally associated with KIV-2 copy number in all 3 ethnicities in the same direction. Following expectations given the known biology of large KIV-2 copy number and Lp(a) secretion, in all 4 cases, the particular SNPs were either associated with an increase in KIV-2 copy number together with a decrease in plasma Lp(a) concentration or with a decrease in KIV-2 copy number and an increase in plasma Lp(a) concentration. Further development of a method for quantification of KIV-2 copy number in an allele-specific manner would allow for determination of phase between KIV-2 copy number and surrounding alleles, allowing tradi- tional linkage disequilibrium calculations (including the calculation of r 2 values).
Eight SNPs that were not associated with KIV-2 copy number were associated with Lp(a) concentration, suggesting that the SNPs are associated with an alternative mechanism for modifying Lp(a) concentration, such as efficiency of transcription or expression. Previous work has identified promoter polymorphisms that would be in some degree of linkage disequilibrium with SNPs in the 5Ј block. 29, 30 As well, rs6919346 in the 3Ј haplotype block is associated with Lp(a) concentrations in the same direction with similar effect size as seen in a previous report. 27 No SNPs outside of LPA were associated with Lp(a), suggesting that previous associations between more distant regions of 6q and Lp(a) might have been related to longer stretches of linkage disequilibrium in Hutterite chromosomes. 27 It has long been recognized that elevated plasma Lp(a) concentration is associated with increased CVD risk [2] [3] [4] and that Lp(a) concentration is largely determined by genetic variation within the LPA locus, including both SNPs and copy number variations. 11, 13 In studies conducted largely in Caucasians, SNPs within LPA have been associated with CVD end points. 31, 32 Furthermore, KIV-2 copy number has been associated with CVD end points in case-control studies 14 -16 and recently in a prospective Mendelian randomization study. 17 However, no multiethnic studies to date have generated both SNP genotypes and the KIV-2 copy number genotype. Including KIV-2 copy number as a covariate in regression analysis reduced the significance of association between LPA SNP genotype and plasma Lp(a) concentration but did not altogether ablate the signal. LPA SNP genotypes, and rs10455872 specifically, explained a much larger extent of Lp(a) variation in European Caucasians than that explained by genetic factors in South Asians and Chinese. The addition of an assay to query KIV-2 copy number produces a meaningful increment over simple SNP genotypes in the explanation of plasma Lp(a) concentration variation and should be included in future studies of Lp(a), especially in epidemiological samples for which DNA but not plasma Lp(a) concentration is available.
The Mendelian randomization approach, in which the association between a disease end point and a risk factor is assessed in the presence or absence of a genetic variant associated with the risk factor, has advantages over even the best designed prospective observational study. 33 As further Mendelian randomization studies of Lp(a) and atherosclerosis susceptibility are performed, including more SNPs and ethnicities, the selection of the genetic markers and the degree of trait variation they explain will greatly affect results. Multiple explanations are possible for the large difference in explained Lp(a) concentration variation observed among ethnicities. Perhaps, plasma Lp(a) concentration is not as strongly determined by genetic factors in South Asians and Chinese compared with European Caucasians. Possibly, SNPs represented on the CVD beadchip are present at higher allele frequencies (thus affording greater statistical power) because of a bias in the initial beadchip design toward European Caucasian samples. The potentially most likely scenario is that additional genetic variants not queried on the CVD beadchip, outside the LPA locus, too rare or with effects too small to be detected in the SHARE sample play a greater role in South Asians and Chinese than in European Caucasians. Indeed, in a preliminary post hoc imputation-based analysis using Hapmap 3 release 2 data, it appears that an untyped LPA SNP, rs7770628, is strongly associated with both KIV-2 copy number and Lp(a) concentrations in Chinese SHARE participants (data not shown). Further identification and categorization of rare and common variants are required in South Asians and Chinese as well as validation of imputationbased methods in de novo investigations of non-European Caucasian populations. The inclusion of CVD end points would have provided an additional dimension to this work, allowing for assessment of association between LPA genomic SNPs and copy number variations and plasma Lp(a) concentration and CVD events. However, SHARE was a cross-sectional study of risk factor prevalence in healthy Canadians, with very few end points recorded. Many significant associations, both genetic and biochemical, have been observed in the SHARE sample, 21, 22, 34, 35 but many more participants would have been required in order to collect enough end points to provide sufficient power to detect genetic associations of LPA SNPs or KIV-2 copy number with cardiovascular events. Because DNA sequencing was not performed and we restricted analysis to genetic variants with a minor allele frequency Ͼ1%, no null alleles were determined.
In conclusion, we have quantified the proportion of plasma Lp(a) variation that can be explained using sex, LDL cholesterol, apoB and both LPA SNPs and KIV-2 copy number; provided evidence of linkage disequilibrium between certain LPA SNPs and genomic KIV-2 copy number; and identified similar LPA haplotype block structures in South Asians, Chinese, and European Caucasians. Future work will be required to uncover genetic factors explaining additional plasma Lp(a) concentration variation, especially in South Asians and Chinese, and to further validate Lp(a) as a CVD risk factor through Mendelian randomization studies that include multiple ethnicities. Both SNPs and KIV-2 copy number are thus genomic determinants of plasma Lp(a) concentration, but relationships differ across ethnic groups, and this will need to be considered in future epidemiological studies that incorporate LPA genetic variation.
